EurekAlert! -
1 May 2016 06:00
(European Society for Radiotherapy and Oncology (ESTRO)) Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer. The findings are presented at the annual meeting of the European Society for Radiotherapy and Oncology - ESTRO35.
Share this Article